An Integrative Approach to Prostate Cancer-Reference-Cited by-同舟云学术

An Integrative Approach to Prostate Cancer

Published:2018-09 Issue:9-10 Volume:24 Page:872-880
ISSN:1075-5535
Container-title:The Journal of Alternative and Complementary Medicine
language:en
Short-container-title:The Journal of Alternative and Complementary Medicine

Author:

Abrams Donald I.¹

Affiliation:

1. Division of Oncology, Department of Medicine, Zuckerberg San Francisco General Hospital and UCSF Center for Integrative Medicine, University of California, San Francisco, San Francisco, CA.

Publisher

Mary Ann Liebert Inc

Subject

Complementary and alternative medicine

Link

https://www.liebertpub.com/doi/pdf/10.1089/acm.2018.0169

Reference58 articles.

1. Benefits and Harms of Prostate-Specific Antigen Screening for Prostate Cancer: An Evidence Update for the U.S. Preventive Services Task Force

2. National Prostate Cancer Screening Rates After the 2012 US Preventive Services Task Force Recommendation Discouraging Prostate-Specific Antigen–Based Screening

3. Radical Prostatectomy or Watchful Waiting in Early Prostate Cancer

4. Appropriateness Criteria for Active Surveillance of Prostate Cancer

5. Obesity and Prostate Cancer: Weighing the Evidence

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fu-Zheng-Yi-Liu Formula inhibits the stem cells and metastasis of prostate cancer via tumor-associated macrophages/C-C motif chemokine ligand 5 pathway in tumor microenvironment;Chinese Journal of Natural Medicines;2024-06

2. Integrative Care: Supporting Patients Through Complementary and Lifestyle Approaches;Transforming Prostate Cancer Care;2024

3. Multifunctional nanocarrier-mediated codelivery for targeting and treatment of prostate cancer;Multifunctional Nanocomposites for Targeted Drug Delivery in Cancer Therapy;2024

4. Changes in Stress Reduction Following a 28-Day Prostate Cancer Patient Empowerment Program (PC-PEP) among Prostate Cancer Survivors;Current Oncology;2023-08-29

5. Integrative medicine in multiple myeloma and plasma cell disorders;Complementary Therapies in Medicine;2023-05